Tracking an FDA advisory panel meeting on Covid vaccines in young children

On the agenda of the FDA's advisory panel on vaccines today: whether to authorize Covid-19 vaccines from Pfizer and Moderna for use in young children.

Parents of America, you’re in the home stretch. In all likelihood, Covid-19 vaccines for children under the age of 5 are days away from being available to your little ones.

The Food and Drug Administration is widely expected to issue long-awaited emergency use authorizations of the pediatric formulations of both the Pfizer-BioNTech and the Moderna Covid vaccines within the next couple of days. Before it does, though, its independent vaccine advisers will weigh the evidence on the safety and efficacy of the vaccines at a meeting Wednesday.

Read the rest…